NCT05738395 is a clinical trial of Questions in Parotid Neoplasms, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Who is sponsoring NCT05738395?

NCT05738395 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

What drugs are being tested in NCT05738395?

Interventions in NCT05738395: Questions.

What condition does NCT05738395 study?

NCT05738395 studies Parotid Neoplasms.

Is NCT05738395 still recruiting?

NCT05738395 is currently status unknown. Last updated 22 February 2023.

Last reviewed 2023-02-22 · How we verify

NCT05738395

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Symptoms of Frey's Syndrome

Status unknown Last updated 22 February 2023

What this trial tests

trial testing Questions in Parotid Neoplasms in 20 participants. Status unknown.

Timeline

1 November 2020

Primary endpoint
1 November 2025

1 November 2025

Quick facts

Lead sponsor	Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 November 2020
Primary completion	1 November 2025
Estimated completion	1 November 2025
Sites	1 location across Italy

Drugs / interventions tested

Questions

Conditions studied

Parotid Neoplasms — all drugs for Parotid Neoplasms →

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

Adults 18 to 65, any sex, with Parotid Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to describe the prevalence of typical and atypical signs and symptoms of Frey's syndrome, the affected areas and the severity of each symptom/sign. Participants will be asked will asked about * Presence or the absence of: a. gustatory sweating; b. gustatory flushing; c. gustatory itching; d. paresthesia; e. pain * Grade of severity: a. absence; b. mild; c. moderate; d. almost severe; e. severe * Affected area: a. preauricular; b. retroauricolar; c. temporal; d. retrangulomandibular; e. cheek

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parotid Neoplasms

Currently open trials in the same condition.

NCT05296109 — Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation · NA · recruiting

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05738395 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Last refreshed: 22 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05738395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing